Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 14,186 Shares

Posted by Brian Himes on Aug 18th, 2026

Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) COO Matthew Fraser Ahearn sold 14,186 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $20.99, for a total value of $297,764.14. Following the completion of the transaction, the chief operating officer directly owned 244,176 shares in the company, valued at approximately $5,125,254.24. The trade was a 5.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

On Monday, August 17th, Matthew Fraser Ahearn sold 8,314 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.10, for a total transaction of $167,111.40.
On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.84, for a total value of $78,072.96.
On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total value of $296,190.08.

Shoulder Innovations Stock Performance

Shares of Shoulder Innovations stock traded up $1.17 during trading hours on Tuesday, reaching $21.09. The company’s stock had a trading volume of 127,644 shares, compared to its average volume of 95,374. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.92 and a current ratio of 10.71. The company’s 50 day simple moving average is $20.60 and its 200 day simple moving average is $16.32. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The stock has a market cap of $439.14 million and a P/E ratio of -10.99.

Shoulder Innovations (NYSE:SI – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. As a group, analysts expect that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Institutional Trading of Shoulder Innovations

A number of hedge funds have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Shoulder Innovations in the 3rd quarter valued at about $28,000. Compass Financial Management LLC acquired a new stake in Shoulder Innovations in the second quarter worth $30,000. Rhumbline Advisers bought a new stake in shares of Shoulder Innovations during the third quarter valued at approximately $54,000. Wells Fargo & Company MN raised its stake in shares of Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after purchasing an additional 2,094 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new stake in shares of Shoulder Innovations in the 4th quarter worth $176,000.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on SI. BTIG Research increased their target price on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, August 7th. UBS Group increased their price target on Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Finally, Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $23.50.

Get Our Latest Stock Report on SI

About Shoulder Innovations

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.